The Bundestag has voted to change the German constitution clearing the way for the new conservative-led government to spend up to €1 trillion through national debt. The move has been doubly ...
The German chancellor-in-waiting, Friedrich Merz, has won a vote in parliament to allow a huge increase in state borrowing that is set to super-charge the country’s military spending.
PAUL B. STARES is General John W. Vessey Senior Fellow for Conflict Prevention at the Council on Foreign Relations, where he also directs the Center for Preventive Action.
Europe’s independent security strategy has passed the point of no return. Nearly doubling defense spending is inevitable, but ensuring that these funds are allocated efficiently and proportionately ...
German lawmakers have voted to allow a huge increase in defence and infrastructure spending - a seismic shift for the country that could reshape European defence. A two-thirds majority of Bundestag ...
The European Commission is seeking to set up collective arms purchasing for the entire bloc, in what would represent a significant transfer of power to Brussels.
MBDA is the only Western company besides American firms capable of producing “the full range of complex weapons,” the CEO said.
The hardest lesson to learn from the war in Ukraine is that there is still no substitute for allies who show up when the fighting begins.
Not even one euro should be taken out of the EU's cohesion funds to fund the new ReArm Europe defence plan, Premier Giorgia Meloni rold the Senate Tuesday. "I take this opportunity to announce that ...
The transatlantic relationship is in turmoil. With the United States and Europe at odds over Western strategy toward Ukraine and Russia, a chorus of European leaders has questioned the reliability of ...
AngloGold Ashanti plc (NYSE:AU) is a global gold mining company registered in the UK with a diverse portfolio of operations, projects, and exploration activities across nine countries on four ...
Despite these positive results, Medtronic plc (NYSE:MDT) faced challenges in its medical-surgical unit, which experienced a 0.4% revenue decline due to shifts in U.S. distributor buying patterns.